CALGARY, AB, Sept. 3, 2025 /CNW/ - Nanalysis Scientific Corp. ("the Company") (TSXV: NSCI) (OTCQX: NSCIF) (FRA: 1N1), a leader in portable Nuclear Magnetic Resonance (NMR) instruments and Magnetic Resonance Imaging (MRI) technology for industrial and research applications, has entered into a licensing agreement with IMRIS Imaging, Inc. ("IMRIS"). The Company and IMRIS have signed a multi-pronged five-year OEM supplier and technology licensing agreement, which includes an upfront payment and builds on a prior contract completed over the last 12 months.
Read more at newswire.ca
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Nanalysis Chosen by IMRIS as Critical Component MRI Supplier
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
